vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and WORKIVA INC (WK). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $247.3M, roughly 1.1× WORKIVA INC). WORKIVA INC runs the higher net margin — 7.7% vs -14.3%, a 22.0% gap on every dollar of revenue. On growth, WORKIVA INC posted the faster year-over-year revenue change (19.9% vs 4.7%). WORKIVA INC produced more free cash flow last quarter ($25.7M vs $3.3M). Over the past eight quarters, WORKIVA INC's revenue compounded faster (18.0% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
EHAB vs WK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $247.3M |
| Net Profit | $-38.7M | $19.0M |
| Gross Margin | — | 80.4% |
| Operating Margin | -12.3% | 25.8% |
| Net Margin | -14.3% | 7.7% |
| Revenue YoY | 4.7% | 19.9% |
| Net Profit YoY | 15.9% | — |
| EPS (diluted) | $-0.76 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $247.3M | ||
| Q4 25 | $270.4M | $238.9M | ||
| Q3 25 | $263.6M | $224.2M | ||
| Q2 25 | $266.1M | $215.2M | ||
| Q1 25 | $259.9M | $206.3M | ||
| Q4 24 | $258.2M | $199.9M | ||
| Q3 24 | $253.6M | $185.6M | ||
| Q2 24 | $260.6M | $177.5M |
| Q1 26 | — | $19.0M | ||
| Q4 25 | $-38.7M | $11.8M | ||
| Q3 25 | $11.1M | $2.8M | ||
| Q2 25 | $5.2M | $-19.4M | ||
| Q1 25 | $17.8M | $-21.4M | ||
| Q4 24 | $-46.0M | $-8.8M | ||
| Q3 24 | $-110.2M | $-17.0M | ||
| Q2 24 | $-200.0K | $-17.5M |
| Q1 26 | — | 80.4% | ||
| Q4 25 | — | 80.7% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 76.6% | ||
| Q4 24 | — | 77.1% | ||
| Q3 24 | — | 76.5% | ||
| Q2 24 | — | 76.8% |
| Q1 26 | — | 25.8% | ||
| Q4 25 | -12.3% | 3.3% | ||
| Q3 25 | 6.4% | -1.5% | ||
| Q2 25 | 6.3% | -10.3% | ||
| Q1 25 | 6.1% | -12.0% | ||
| Q4 24 | -16.0% | -6.7% | ||
| Q3 24 | -38.6% | -11.7% | ||
| Q2 24 | 4.3% | -13.0% |
| Q1 26 | — | 7.7% | ||
| Q4 25 | -14.3% | 4.9% | ||
| Q3 25 | 4.2% | 1.2% | ||
| Q2 25 | 2.0% | -9.0% | ||
| Q1 25 | 6.8% | -10.4% | ||
| Q4 24 | -17.8% | -4.4% | ||
| Q3 24 | -43.5% | -9.2% | ||
| Q2 24 | -0.1% | -9.9% |
| Q1 26 | — | $0.33 | ||
| Q4 25 | $-0.76 | $0.21 | ||
| Q3 25 | $0.22 | $0.05 | ||
| Q2 25 | $0.10 | $-0.35 | ||
| Q1 25 | $0.35 | $-0.38 | ||
| Q4 24 | $-0.92 | $-0.15 | ||
| Q3 24 | $-2.20 | $-0.31 | ||
| Q2 24 | $0.00 | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $334.3M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | — |
| Total Assets | $1.2B | $1.4B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $334.3M | ||
| Q4 25 | $43.6M | $338.8M | ||
| Q3 25 | $56.9M | $315.9M | ||
| Q2 25 | $37.1M | $284.3M | ||
| Q1 25 | $39.5M | $242.0M | ||
| Q4 24 | $28.4M | $301.8M | ||
| Q3 24 | $45.7M | $248.2M | ||
| Q2 24 | $28.5M | $267.9M |
| Q1 26 | — | — | ||
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $534.0M | $-5.4M | ||
| Q3 25 | $566.8M | $-36.9M | ||
| Q2 25 | $552.4M | $-66.5M | ||
| Q1 25 | $543.2M | $-75.7M | ||
| Q4 24 | $523.5M | $-41.7M | ||
| Q3 24 | $566.1M | $-50.8M | ||
| Q2 24 | $674.3M | $-77.7M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.4B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | — |
| Free Cash FlowOCF − Capex | $3.3M | $25.7M |
| FCF MarginFCF / Revenue | 1.2% | 10.4% |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $171.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.4M | $51.0M | ||
| Q3 25 | $37.8M | $46.2M | ||
| Q2 25 | $10.6M | $50.3M | ||
| Q1 25 | $17.9M | $-7.4M | ||
| Q4 24 | $-4.1M | $44.0M | ||
| Q3 24 | $28.4M | $18.9M | ||
| Q2 24 | $9.6M | $-14.0K |
| Q1 26 | — | $25.7M | ||
| Q4 25 | $3.3M | $50.7M | ||
| Q3 25 | $36.2M | $46.1M | ||
| Q2 25 | $8.7M | $49.3M | ||
| Q1 25 | $17.6M | $-8.1M | ||
| Q4 24 | $-4.7M | $43.2M | ||
| Q3 24 | $27.7M | $18.7M | ||
| Q2 24 | $8.9M | $-122.0K |
| Q1 26 | — | 10.4% | ||
| Q4 25 | 1.2% | 21.2% | ||
| Q3 25 | 13.7% | 20.5% | ||
| Q2 25 | 3.3% | 22.9% | ||
| Q1 25 | 6.8% | -3.9% | ||
| Q4 24 | -1.8% | 21.6% | ||
| Q3 24 | 10.9% | 10.1% | ||
| Q2 24 | 3.4% | -0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 0.1% | ||
| Q3 25 | 0.6% | 0.0% | ||
| Q2 25 | 0.7% | 0.5% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.2% | 0.4% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.3% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.31× | ||
| Q3 25 | 3.41× | 16.57× | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
WK
| Subscription and support | $225.4M | 91% |
| Other | $22.0M | 9% |
